Individuals with obstructive sleep apnea (OSA) who have unsuccessfully tried other remedies have a new treatment available. The Food and Drug Administration (FDA) announced it has approved the first fully implantable neurostimulator to treat the condition, but only as a second-line therapy. Inspire Upper Airway Stimulation therapy, made by Inspire Medical Systems, is an implant that keeps a patient’s airway open during sleep by stimulating the hypoglossal nerve, causing the upper airway muscles to contract and pull the base of the tongue forward. The device was approved specifically for patients with moderate to severe OSA who cannot use continuous positive ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.